GAP / ILD-GAP stage I (n = 39/76.5%) | GAP / ILD-GAP stage II (n = 12/23.5%) | P-value | |
---|---|---|---|
Number of deaths | 18 (46.2) | 9 (75.0) | 0.080 |
Hospitalization due to respiratory illness | 1.0 ± 1.4 (0–5) | 1.6 ± 3.1 (0–11) | 0.343 |
Hospitalization due to cardiac illness | 0.5 ± 1.0 (0–5) | 1.0 ± 1.8 (0–4) | 0.366 |
Use of Oxygen | 6 (15.4) | 1 (8.3) | 1.000a |
Median survival | 152.0 (93.0–211.0) | 61.0 (25.2–96.8) | 0.017 |
Observed 1-y deaths* | 0 (0.0) | 1 (8.3) | 0.245 |
Observed 2-y deaths** | 5 (14.3) | 1 (9.1) | 1.000 |
Observed 3-y deaths*** | 6 (17.6) | 3 (27.3) | 0.666 |